Literature DB >> 24823399

Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution.

Sarita Sasidharanpillai1, Najeeba Riyaz, Uma Rajan, Manikoth P Binitha, Anza Khader, Olasseri K Reena Mariyath, Rajiv John, Jayasree Puravoor.   

Abstract

BACKGROUND: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe drug reaction which can mimic a viral infection, an autoimmune disease or a neoplastic disease. AIMS: To study the clinical and epidemiological aspects of DRESS and to identify the precipitating drugs.
METHODS: All patients admitted to the dermatology ward of our tertiary care hospital from 1 st October 2010 to 30 th September 2013 with probable or definite DRESS as per the RegiSCAR scoring system were included in this prospective study. The clinical manifestations observed in the study population were studied and the common offending drugs were identified.
RESULTS: During the 3 year study period, 26 patients fulfilled criteria for probable or definite DRESS. In more than 50% of cases, the culprit drug was phenytoin. Most common symptoms observed were fever, rash and facial edema. Liver was the most common internal organ affected. Most of the patients responded to withdrawal of the drug and administration of steroids for 3-6 weeks. One patient with dapsone-induced DRESS died.
CONCLUSIONS: Intense facial erythema and edema and an elevated eosinophil count were not found to be bad prognostic factors. In most instances the flare ups during the course of the disease could be managed with a slower tapering of steroids. More prospective studies on DRESS are required to assess the prognostic factors and to formulate better diagnostic criteria.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24823399     DOI: 10.4103/0378-6323.132249

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  5 in total

Review 1.  Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy.

Authors:  Enes Akyüz; Betül Köklü; Cansu Ozenen; Alina Arulsamy; Mohd Farooq Shaikh
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

2.  Drug reaction with eosinophilia and systemic symptoms without skin rash.

Authors:  Sarita Sasidharanpillai; Manikoth P Binitha; Neeraj Manikath; Anisha K Janardhanan
Journal:  Indian J Pharmacol       Date:  2015 Nov-Dec       Impact factor: 1.200

3.  Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: Case report of severe multiorgan involvement to perindopril/amlodipine combination antihypertensive.

Authors:  Linda Chan; Charles Chan; David K Cook
Journal:  JAAD Case Rep       Date:  2018-01-24

4.  Diagnostic criteria for drug rash and eosinophilia with systemic symptoms.

Authors:  Ashok Kumar Pannu; Atul Saroch
Journal:  J Family Med Prim Care       Date:  2017 Jul-Sep

5.  A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab.

Authors:  Niharika Jha; Emy Alexander; Bimal Kanish; Dinesh K Badyal
Journal:  Indian Dermatol Online J       Date:  2018 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.